Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
Nifty below 22,850 mark; pharma shares decline     Back
(19 Mar 2024)
The key benchmark indices extended the losses in the mid-afternoon trade. The Nifty slipped below the 21,850 mark. Pharma shares declined after advancing in the past trading session.

At 14:27 IST, the barometer index, the S&P BSE Sensex, was down 695.14 points or 0.96% to 72,053.28. The Nifty 50 index slipped 221.90 points or 1.01% to 21,834.10.

In the broader market, the S&P BSE Mid-Cap index declined 1.15% and the S&P BSE Small-Cap index shed 0.83%.

The market breadth was weak. On the BSE, 1,199 shares rose and 2,561 shares fell. A total of 113 shares were unchanged.

Buzzing Index:

The Nifty Pharma Index declined 1.60% to 18,512.70. The index rose 0.51% in the past trading session.

Cipla (down 2.68%), Dr Reddys Laboratories (down 2.35%), Aurobindo Pharma (down 2.25%), Divis Laboratories (down 2.22%) and Torrent Pharmaceuticals (down 1.91%) were the top losers. Among the other losers were Sanofi India (down 1.66%), Laurus Labs (down 1.56%), Lupin (down 1.51%), Alkem Laboratories (down 1.5%) and Glenmark Pharmaceuticals (down 1.41%) declined.

On the other hand, Natco Pharma (up 1.39%), Glaxosmithkline Pharmaceuticals (up 0.59%) and Pfizer (up 0.47%) advanced.

Numbers to Track:

The yield on India's 10-year benchmark federal paper fell 0.01% to 7.086 as compared with the previous close of 7.087.

In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 83.0000, compared with its close of 82.9075 during the previous trading session.

MCX Gold futures for 5 April 2024 settlement shed 0.24% to Rs 65,450.

The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.48% to 103.93.

The United States 10-year bond yield declined 0.30% to 4.327.

In the commodities market, Brent crude for May 2024 settlement lost 21 cents or 0.24% to $86.68 a barrel.

Stocks in spotlight:

Grasim Industries shed 0.84%. The company said an investment of Rs 1,250 crore, or $150 million, made by the World Bank Group's private sector arm, the International Finance Corporation (IFC), by way of subscription to non convertible debentures to be issued by the firm.

L&T Finance Holdings shed 0.27%. The NBFC announced that its board has approved the raising of funds by issuance of non-convertible debentures (NCDs) in one or more tranches, such that at any point of time the NCDs issued and outstanding does not exceed Rs 1,01,000 crore.

Bondada Engineering was locked in upper circuit of 5% at Rs 815.05 after the company has received a letter of intent (LoI) from the Singareni Collieries Company (SCCL) for grant of work order worth Rs 433 crore.

Top